-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, St21aFKJklUwuuW55wHQk29UbcikwPHV073GYSM+jVJbTRi+UmU4k4s+fe1edI/Y 3Q3ChwQzLGB9RjWXEsM3Sw== 0001209191-07-006153.txt : 20070130 0001209191-07-006153.hdr.sgml : 20070130 20070130195202 ACCESSION NUMBER: 0001209191-07-006153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070130 DATE AS OF CHANGE: 20070130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Tony CENTRAL INDEX KEY: 0001320362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07565999 BUSINESS ADDRESS: BUSINESS PHONE: 44(0)1799-532300 MAIL ADDRESS: STREET 1: CHESTERFORD RESEARCH PARK CITY: LITTLE CHESTERFORD STATE: X0 ZIP: CB10 1XL T 4 1 bsf26824_bsf7ts.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-01-26 1 0000913275 Solexa, Inc. SLXA 0001320362 Smith Tony C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 VP & Chief Scientific Officer Stock Option (Right to Buy) 4.27 2007-01-26 4 D 0 44318 0.00 D 2012-05-22 Common Stock 44318 0 D Stock Option (Right to Buy) 1.75 2007-01-26 4 D 0 8863 0.00 D 2013-05-19 Common Stock 8863 0 D Stock Option (Right to Buy) 1.28 2007-01-26 4 D 0 10651 0.00 D 2014-09-10 Common Stock 10651 0 D Stock Option (Right to Buy) 1.28 2007-01-26 4 D 0 16639 0.00 D 2014-09-27 Common Stock 16639 0 D Stock Option (Right to Buy) 1.28 2007-01-26 4 D 0 4088 0.00 D 2014-09-27 Common Stock 4088 0 D Stock Option (Right to Buy) 1.28 2007-01-26 4 D 0 4088 0.00 D 2014-09-27 Common Stock 4088 0 D Stock Option (Right to Buy) 5.97 2007-01-26 4 D 0 88000 0.00 D 2015-09-06 Common Stock 88000 0 D Stock Option (Right to Buy) 8.60 2007-01-26 4 D 0 75000 0.00 D 2016-02-02 Common Stock 75000 0 D This option, which provided for vesting of 25% on January 28, 2003 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 15,245 shares at an exercise price of $12.41 per share. This option, which provided for vesting of 25% on December 3, 2003 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 3,048 shares at an exercise price of $5.09 per share. This option, which provided for vesting of 25% on September 10, 2005 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 3,663 shares at an exercise price of $3.72 per share. This option, which provided for vesting of 25% on September 10, 2005 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 5,723 shares at an exercise price of $3.72 per share. This option, which provided for vesting of 25% on June 1, 2005 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 1,406 shares at an exercise price of $3.72 per share. This option, which provided for vesting of 25% on April 1, 2005 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 1,406 shares at an exercise price of $3.72 per share. This option, which provided for vesting monthly and ratably over the 48 month period beginning on September 6, 2005, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 30,272 shares at an exercise price of $17.35 per share. This option, which provided for vesting monthly and ratably over the 48 month period beginning on February 2, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 25,800 shares at an exercise price of $25.00 per share. /s/ Tony Smith, by Kathy San Roman, attorney-in-fact 2007-01-29 -----END PRIVACY-ENHANCED MESSAGE-----